NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

US FDA limits use of Covid-19 antibody therapies from Regeneron and Lilly

By NS Healthcare Staff Writer 25 Jan 2022

The US agency revised the EUAs for Lilly’s bamlanivimab plus etesevimab regimen, and Regeneron’s REGEN-COV, based on the recent data

US FDA approves remdesivir to treat non-hospitalised Covid-19....

The US FDA has also expanded the emergency use authorisation of remdesivir

APS gets FDA IND approval for APS03118 to....

APS03118 is a new drug that targets patients with various advanced cancer

Amgen’s Lumakras approved in Japan to treat KRAS....

The MHLW approval was based on positive data from the Phase 2

Sputnik V shows superior antibody levels against Omicron....

People who received two doses of Sputnik V showed high levels of

Pharmaceuticals

UCB to acquire epilepsy drugmaker Zogenix for up to $1.9bn
20 Jan 22

Biotechnology firm Altos Labs launches with $3bn funding
20 Jan 22

US FDA limits use of Covid-19 antibody therapies from Regeneron and Lilly

US FDA approves remdesivir to treat non-hospitalised Covid-19....

APS gets FDA IND approval for APS03118 to....

Amgen’s Lumakras approved in Japan to treat KRAS....

Sputnik V shows superior antibody levels against Omicron....

Pharmaceuticals

UCB to acquire epilepsy drugmaker Zogenix for up to $1.9bn
20 Jan 22

Biotechnology firm Altos Labs launches with $3bn funding
20 Jan 22

AstraZeneca’s STRIDE regimen shows positive survival outcomes in liver cancer trial
19 Jan 22

Patient Care

Thermo Fisher’s Oncomine Dx approved in US to identify NSCLC patients eligible for Rybrevant
10 Dec 21

Omicron variant spreads worldwide, with limited scientific information
29 Nov 21

Fujifilm rolls out ColoAssist PRO visualisation system for colonoscopies
25 Nov 21

Nutraceuticals

How sweet are sweeteners?
03 Nov 21

European Flavour Association: From farm to fork
28 Oct 21

Hope on the horizon for lactose intolerance
14 Oct 21

NS Healthcare is using cookies

UCB to acquire epilepsy drugmaker Zogenix for up to $1.9bn20 Jan 22

Biotechnology firm Altos Labs launches with $3bn funding20 Jan 22

AstraZeneca’s STRIDE regimen shows positive survival outcomes in liver cancer trial19 Jan 22

Thermo Fisher’s Oncomine Dx approved in US to identify NSCLC patients eligible for Rybrevant 10 Dec 21

Omicron variant spreads worldwide, with limited scientific information 29 Nov 21

Fujifilm rolls out ColoAssist PRO visualisation system for colonoscopies 25 Nov 21

How sweet are sweeteners?03 Nov 21

European Flavour Association: From farm to fork28 Oct 21

Hope on the horizon for lactose intolerance14 Oct 21

OUR TITLES

Novavax’ protein-based Covid-19 vaccine approved in....13 Jan 22

Gilead selects AWS for development and....30 Nov 21

Click Therapeutics secures $52m in Series....25 Oct 21

The psychological toll of Covid-19 on....14 Sep 21

Merck to acquire biopharma CDMO Exelead....07 Jan 22

Novartis to acquire Gyroscope Therapeutics for....23 Dec 21

Sanofi to buy immuno-oncology firm Amunix....22 Dec 21

CSL agrees to buy Swiss firm....15 Dec 21

Lilly partners with Entos to develop....07 Jan 22

AstraZeneca teams up with Ionis to....30 Dec 21

Novavax extends manufacturing agreement with South....24 Dec 21

Novartis teams up with BeiGene for....21 Dec 21

UCB to acquire epilepsy drugmaker Zogenix for up to $1.9bn
20 Jan 22

Biotechnology firm Altos Labs launches with $3bn funding
20 Jan 22

AstraZeneca’s STRIDE regimen shows positive survival outcomes in liver cancer trial
19 Jan 22

Thermo Fisher’s Oncomine Dx approved in US to identify NSCLC patients eligible for Rybrevant
10 Dec 21

Omicron variant spreads worldwide, with limited scientific information
29 Nov 21

Fujifilm rolls out ColoAssist PRO visualisation system for colonoscopies
25 Nov 21

How sweet are sweeteners?
03 Nov 21

European Flavour Association: From farm to fork
28 Oct 21

Hope on the horizon for lactose intolerance
14 Oct 21

Novavax’ protein-based Covid-19 vaccine approved in....
13 Jan 22

Gilead selects AWS for development and....
30 Nov 21

Click Therapeutics secures $52m in Series....
25 Oct 21

The psychological toll of Covid-19 on....
14 Sep 21

Merck to acquire biopharma CDMO Exelead....
07 Jan 22

Novartis to acquire Gyroscope Therapeutics for....
23 Dec 21

Sanofi to buy immuno-oncology firm Amunix....
22 Dec 21

CSL agrees to buy Swiss firm....
15 Dec 21

Lilly partners with Entos to develop....
07 Jan 22

AstraZeneca teams up with Ionis to....
30 Dec 21

Novavax extends manufacturing agreement with South....
24 Dec 21

Novartis teams up with BeiGene for....
21 Dec 21